|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8740 EUR | +1.86% |
|
-2.35% | -43.10% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |  |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 76.29M | |
| 57.4x | 6.55x | -0.83x | 5.26x | 21.56x | 30.87x | 2.6% | 318B | |
| 24.6x | 2.07x | -18.42x | 3.37x | 12.01x | 19.63x | 1.6% | 72.22B | |
| 11.13x | 11.78x | 0.07x | 5.69x | 8.76x | 9.62x | - | 8.89B | |
| 16.56x | 1.43x | 0.82x | 2.09x | 7.18x | 8.58x | 2.7% | 8.25B | |
| 22.11x | 5.88x | 2.22x | 6.27x | 17.83x | 18.64x | -.--% | 4.23B | |
| 30.95x | - | 0.2x | 5.89x | 16.85x | 27.29x | - | 3.58B | |
| 36.87x | 2.2x | -1.2x | 2.08x | 25.44x | 38.27x | 0.84% | 3.23B | |
| 108.09x | - | -0.66x | - | - | - | -.--% | 2.72B | |
| 13.02x | 0.87x | 0.92x | 1.19x | 29.9x | -81.45x | 3.93% | 1.04B | |
| 49.36x | - | -0.09x | - | - | - | - | 978M | |
| -7.54x | 12.61x | 0.46x | 208.76x | -6.72x | -5.26x | -.--% | 970M | |
| 41.8x | 6.55x | -1.08x | 13.81x | 28.99x | 34.11x | - | 877M | |
| Average | 33.70x | 5.55x | -1.47x | 25.44x | 16.18x | 10.03x | 1.46% | 32.68B | |
| Weighted average by Cap. | 49.35x | 5.74x | -3.72x | 5.35x | 19.30x | 27.61x | 2.37% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
